Anticancer research | Journament

Journal Ranking

#4267 / 33,959
📉 Poor
Overall Score
38.6/100
Score Breakdown
Engagement
31
Accessibility
35
Timeliness
50
Diversity
30
Innovation
40
Community Impact
35
Ethics & Transparency
0
Content Quality
0
Editorial Diversity
0
Publication Regularity
0
Geographic Reach
0
Updated 3 weeks ago

Anticancer research

Login or register to claim ownership or editorship of this journal.
Quality Widget - Embed on Your Website

Display your journal's quality scores on your website with our beautiful, self-contained widget. Choose between two embedding methods below.

One-Line JavaScript Embed (Recommended):
Advantages:
  • ✅ Simpler integration (just one line of code)
  • ✅ Better SEO (content is in same DOM)
  • ✅ No iframe limitations
  • ✅ Fully self-contained (no dependencies)
  • ✅ Works on any website regardless of CSS framework
  • ✅ Clickable badges link to full journal page
iFrame Embed Code:
Limitations:
  • ⚠️ Display-only (scores not clickable due to iframe constraints)
  • ⚠️ May have SEO limitations
  • ⚠️ Potential CORS/CSP issues on some websites
Preview:
Indexings
ncbi ulakbim
Short Name Anticancer Res
Abbreviated Name anticancer res
ISSN 1791-7530
Aim and Scope
URL http://ar.iiarjournals.org
Author Instructions

Publications Per Year

Recent Articles (31 total)

2019
Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells.
Alturkistani, Azhaar;Ghonem, Nisanne;Power-Charnitsky, Verna-Ann;Pino-Figueroa, Alejandro;Migliore, Mattia M;
Vol. 39 , No. 10 , pp. 5297-5310
438 views DOI Abstract
2019
Propagermanium Induces NK Cell Maturation and Tends to Prolong Overall Survival of Patients With Refractory Cancer.
Kikuchi, Shojiro;Noguchi, Kazuma;Wakai, Keiko;Hamazaki, Yoko;Tozawa, Katsuyuki;Jomori, Takahito;Sasako, Mitsuru;Miwa, Hiroto;
Vol. 39 , No. 9 , pp. 4687-4698
429 views DOI Abstract
2019
Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer
Shin SH;Park Y;Hwang DW;Song KB;Lee JH;Kwon J;Yoo C;Alshammary S;Kim SC;;
Vol. 39 , No. 2 , pp. -
405 views Abstract
2019
CD2 for Prevention of Oral Mucositis in Patients With Head and Neck Tumors: A Multicentric Randomized Study.
DE Sanctis, Vitaliana;Belgioia, Liliana;Cante, Domenico;LA Porta, Maria R;Caspiani, Orietta;Guarnaccia, Roberta;Argenone, Angela;Muto, Paolo;Musio, Daniela;DE Felice, Francesca;Maurizi, Francesca;Bunkhelia, Feisal;Ruo Redda, Maria Grazia;Reali, Alessia;Valeriani, Maurizio;Osti, Mattia F;Alterio, Daniela;Bacigalupo, Almalina;Russi, Elvio G;
Vol. 39 , No. 4 , pp. 1935-1942
379 views DOI Abstract
2019
Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial Cancer.
Yasuoka, Shotaro;Yuasa, Takeshi;Nishimura, Noriko;Ogawa, Masahiro;Komai, Yoshinobu;Numao, Noboru;Yamamoto, Shinya;Kondo, Yukihiro;Yonese, Junji;
Vol. 39 , No. 7 , pp. 3887-3892
378 views DOI Abstract
2019
Impact of Extravasated Platelet Activation and Podoplanin-positive Cancer-associated Fibroblasts in Pancreatic Cancer Stroma.
Miyashita, Tomoharu;Tajima, Hidehiro;Gabata, Ryosuke;Okazaki, Mitsuyoshi;Shimbashi, Hiroyuki;Ohbatake, Yoshinao;Okamoto, Koichi;Nakanuma, Sinichi;Sakai, Seisho;Makino, Isamu;Kinoshita, Jun;Hayashi, Hironori;Nakamura, Keishi;Takamura, Hiroyuki;Ninomiya, Itasu;Fushida, Sachio;Harmon, John W;Ohta, Tetsuo;
Vol. 39 , No. 10 , pp. 5565-5572
348 views DOI Abstract
2019
Resveratrol Modulates the Redox-status and Cytotoxicity of Anticancer Drugs by Sensitizing Leukemic Lymphocytes and Protecting Normal Lymphocytes.
Ivanova, Donika;Zhelev, Zhivko;Semkova, Severina;Aoki, Ichio;Bakalova, Rumiana;
Vol. 39 , No. 7 , pp. 3745-3755
340 views DOI Abstract
2019
Peroxiredoxin V Reduces β-Lapachone-induced Apoptosis of Colon Cancer Cells
Liu Y;Kwon T;Kim JS;Chandimali N;Jin YH;Gong YX;Xie DP;Han YH;Jin MH;Shen GN;Jeong DK;Lee DS;Cui YD;Sun HN;;
Vol. 39 , No. 7 , pp. -
334 views Abstract
2018
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
No Author Found
Vol. 38 , No. 1
326 views DOI
1999
20-Cyclopropyl-cholecalciferol vitamin D<inf>3</inf>analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines
Koike, M.
Vol. 19 , pp. 1689-1697
287 views
View All 31 Articles
39
Overall
Poor
31
35
30
40
35
50
0
0
0
0
0
Journament

Overall Quality Score

38.6/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.0/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

35.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

30.0/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

40.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

35.0/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

50.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Ethics & Transparency Score

0.0/100

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

0.0/100

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

0.0/100

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

0.0/100

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

0.0/100

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.